SAN DIEGO--(BUSINESS WIRE)--MultiCell Technologies, Inc. (OTCBB:MCET), developing first-in-class drugs based on advanced immune system modulation and other proprietary technologies, announced that Dr. Stephen Chang, Chief Executive Officer of MultiCell, will be interviewed by leading online microcap investment news broadcaster MN1.com, on October 24, 2006, at 12:30 p.m. Eastern Time.
